Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy
Narsireddy Amreddy,1,2 Ranganayaki Muralidharan,1,2 Anish Babu,1,2 Meghna Mehta,2,3 Elyse V Johnson,4 Yan D Zhao,2,5 Anupama Munshi,2,3 Rajagopal Ramesh1,2,6 1Department of Pathology, 2Stephenson Cancer Center, 3Department of Radiation Oncology University of Oklahoma Health Sciences Center, Oklahom...
Guardado en:
Autores principales: | Amreddy N, Muralidharan R, Babu A, Mehta M, Johnson EV, Zhao YD, Munshi A, Ramesh R |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b370ec7e044142548938ea3bc220c120 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Heterophase fcc-2H-fcc gold nanorods
por: Zhanxi Fan, et al.
Publicado: (2020) -
Intracellular delivery of doxorubicin encapsulated in novel pH-responsive chitosan/heparin nanocapsules
por: Thomas MB, et al.
Publicado: (2013) -
Co-Delivery of Paclitaxel and Doxorubicin by pH-Responsive Prodrug Micelles for Cancer Therapy
por: Jiang Y, et al.
Publicado: (2020) -
Doxorubicin (DOX) Gadolinium–Gold-Complex: A New Way to Tune Hybrid Nanorods as Theranostic Agent
por: Khan M, et al.
Publicado: (2021) -
pH-responsive charge-reversal polymer-functionalized boron nitride nanospheres for intracellular doxorubicin delivery
por: Feng SN, et al.
Publicado: (2018)